HCA HCA Healthcare, Inc.

NYSE hcahealthcare.com


$ 468.05 $ -7.12 (-1.53 %)    

Friday, 31-Oct-2025 18:53:52 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 459.68
$ 465.39
$ 454.00 x 1
$ 475.00 x 25
-- - --
$ 288.25 - $ 478.19
1,511,322
na
104.9B
$ 0.89
$ 16.53
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 08-04-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-13-2025 12-31-2024 10-K
5 10-31-2024 09-30-2024 10-Q
6 07-29-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-16-2024 12-31-2023 10-K
9 10-26-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 04-27-2023 03-31-2023 10-Q
12 02-17-2023 12-31-2022 10-K
13 11-01-2022 09-30-2022 10-Q
14 08-01-2022 06-30-2022 10-Q
15 05-03-2022 03-31-2022 10-Q
16 02-18-2022 12-31-2021 10-K
17 11-01-2021 09-30-2021 10-Q
18 08-02-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-19-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 07-30-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 02-20-2020 12-31-2019 10-K
25 11-01-2019 09-30-2019 10-Q
26 08-02-2019 06-30-2019 10-Q
27 05-03-2019 03-31-2019 10-Q
28 02-21-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-03-2018 06-30-2018 10-Q
31 05-08-2018 03-31-2018 10-Q
32 02-23-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-04-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 02-22-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 05-06-2016 03-31-2016 10-Q
40 02-26-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jefferies-maintains-buy-on-hca-healthcare-raises-price-target-to-525

Jefferies analyst Brian Tanquilut maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $485 to $525.

 ubs-maintains-buy-on-hca-healthcare-raises-price-target-to-525

UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $495 to $525.

 b-of-a-securities-maintains-neutral-on-hca-healthcare-raises-price-target-to-470

B of A Securities analyst Joanna Gajuk maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $...

 goldman-sachs-maintains-buy-on-hca-healthcare-raises-price-target-to-520

Goldman Sachs analyst Scott Fidel maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $470 to $...

 td-cowen-maintains-buy-on-hca-healthcare-raises-price-target-to-490

TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $380 to $490.

 rbc-capital-maintains-outperform-on-hca-healthcare-raises-price-target-to-482

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $449 ...

 barclays-maintains-overweight-on-hca-healthcare-raises-price-target-to-494

Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $445 to $...

 stephens--co-maintains-overweight-on-hca-healthcare-raises-price-target-to-500

Stephens & Co. analyst Raj Kumar maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from...

 truist-securities-maintains-buy-on-hca-healthcare-raises-price-target-to-495

Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $4...

 oppenheimer-maintains-outperform-on-hca-healthcare-raises-price-target-to-500

Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target fro...

 mizuho-maintains-outperform-on-hca-healthcare-raises-price-target-to-505

Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $475 to $505.

 keybanc-maintains-overweight-on-hca-healthcare-raises-price-target-to-475

Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $465 ...

 stocks-soar-to-records-after-weak-inflation-ford-jumps-10-whats-moving-markets-friday

Wall Street surged to fresh all-time highs Friday as a softer-than-expected inflation reading strengthened market conviction th...

 americas-leading--hospital-operator-hca-healthcare-outperforms-citing-solid-patient-volumes

HCA Healthcare beats Q3 estimates with 9.6% revenue growth and higher earnings, raising its 2025 guidance on strong patient vol...

 hca-healthcare-raises-fy2025-gaap-eps-guidance-from-2550-2700-to-2700-2800-vs-2633-est-raises-fy2025-sales-guidance-from-74000b-76000b-to-75000b-76500b-vs-75020b-est

HCA Healthcare (NYSE:HCA) raises FY2025 GAAP EPS guidance from $25.50-$27.00 to $27.00-$28.00 vs $26.33 analyst estimate. Raise...

 hca-healthcare-q3-adj-eps-696-beats-572-estimate-sales-19161b-beat-18569b-estimate

HCA Healthcare (NYSE:HCA) reported quarterly earnings of $6.96 per share which beat the analyst consensus estimate of $5.72 by ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION